Construction of recombinant sox2-encoding plasmids that regulate pluripotency of breast cancer stem cells from indonesian patient
DOI:
https://doi.org/10.12928/pharmaciana.v9i1.11919Keywords:
construction, pluripotency, recombinant, Sox2, Cancer Stem Cell (CSC)Abstract
A therapy development with recombinant protein is a new and potential innovation to destroy cancer stem cells (CSCs). Various ways of killing CSCs include the provision of polyvalent anti-protein antibodies that code pluripotency. Therefore, it takes a mixture of Oct-4, c-Myc, Sox2, and Klf4 protein antigens that can stimulate the formation of polyvalent antibodies. This study aimed to construct Sox2 recombinant by identifying the target genes by reverse transcriptase PCR and then arranging their designs to be inserted into the cloning vector pET101/D-TOPO®. The target gene was developed by finding the complete sequences of Sox2 nucleotides on the NCBI GenBank. The growth on LB-ampicillin agar plates was amplified by PCR to obtain colonies with pET101/D-TOPO® vectors and inserts of the pluripotent gene of CSCs, then the PCR results were observed through electrophoresis. A total of fifteen colonies have DNA bands with a base pair of about 300 bp in length. The recombinant clones produced Sox2 genes with a base length of 330 bp.
References
Al-Dhfyan A., 2013, Embryonic Signature in Breast Cancers; Pluripotency Roots of Cancer Stem Cells, Saudi Pharmaceutical Journal, 21(2): 229–232.
Aulia G., 2012, Modulasi stress oksidatif pada ketahanan hidup sel punca kanker payudara (CD24-/CD44+) melalui Induksi Rotenon: tinjauan pada ekspresi MnSOD, Master Thesis, Jakarta: Fakultas Kedokteran Universitas Indonesia.
Barton G. J., 2007, Sequence alignment for molecular replacement, Acta Crystallographica Section D Biological Crystallography, D64: 25-32.
Comtesse N., Zippel A., Walle S., Monz D., Backes C., Fischer U., Mayer J., Ludwig N., Hildebrandt A., Keller A., Steudel W. I., Lenhof H. P., and Meese E., 2005, Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. Proceedings of the National Academy of Sciences of the United States of America, 102(27): 9601–9606.
Dong C., Wilhelm D., and Koopman P, 2004, Sox Genes and Cancer, Cytogenetic and Genome Research, 105(2-4): 442–447.
Gure A. O., Stockert E., Scanlan M. J., Keresztes R. S., Jager D., Altorki N. K., Old L. J., and Chen Y. T., 2000, Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America, 97(8): 4198–4203.
Hussenet T., Dali S., Exinger J., Monga B., Jost B., Dembele D., Martinet N., Thibault C., Huelsken J., Brambilla E. and Manoir S, 2010, SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas. Plos One, 5(1): e8960.
Lengerke C., Fehm T., Kurth R., Neubauer H., Scheble V., Müller F., Schneider F., Petersen K., Wallwiener D., Kanz L., Fend F., Perner S., Bareiss P. M., and Staebler A., 2011, Expression of The Embryonic Stem Cell Marker SOX2 in Early-Stage Breast Carcinoma, BMC Cancer, 11(42): 1-10.
Li X. L., Eishi Y. B., Bai Y. Q., Sakai H., Akiyama Y., Tani M., Takizawa T., Koike M. and Yuasa Y, 2004, Expression of the SRY-Related HMG Box Protein SOX2 in Human Gastric Carcinoma, International Journal of Oncology, 24(2): 257–263.
Lynch M. D., Cariati M., and Purushotham A. D., 2006, Breast Cancer: Stem Cells and Prospects for Therapy, Breast Cancer Research, 8(3): 211.
Marshall O. J., 2004, PerlPrimer: Cross-Platform, Graphical Primer Design for Standard, Bisulphite and Real-Time PCR, Bioinformatics, 20(15): 2471-2472.
Mathieu J., Alvarez E., and Alvarez P., 2014, Recombination-Assisted Megaprimer (RAM) Cloning, MethodsX, 1: 23-29.
Sanada Y., Yoshida K., Ohara M., Oeda M., Konishi K., and Tsutani, 2006, Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2 - comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas. 32(2): 164–170.
Sattler H. P., Lensch R., Rohde V., Zimmer E., Meese E., Bonkhoff H., Retz M., Zwergel T., Bex A., Stoeckle M., and Wullich B, 2000, Novel amplification unit at chromosome 3q25-q27 in human prostate cancer, Prostate, 45(3):207–215.
Septelia I.W., Reni P., Naroeni A., Sonar S. P., Endang W. B., Amarila M., and Budiman B, 2011, Characterization of manganese superoxide dismutase expression (mnsod) in human breast cancer stem cells and its correlation with cell pluripotency, Medicine & Health, 6(1): 208.
Shi Z., Bai R., Fu Z., Zhu Y., Wang R., and Zheng S, 2012, Induced pluripotent stem cell-related genes influence biological behavior and 5-fluorouracil sensitivity of colorectal cancer cells, J Zhejiang Univ Sci B, 13(1): 11–19.
Takahashi K. and Yamanaka S, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126(4): 663-676.
Tippmann H., 2004, Software review: analysis for free: comparing programs for sequence analysis, Briefings in Bioinformatics, 5(1): 82-87.
Wacker M. and Godard M., 2005, Analysis of One-Step and Two-Step Real-Time RT-PCR Using SuperScript III, J Biomol Tech, 16(3): 266–271.
Downloads
Published
Issue
Section
License
Authors who publish with Pharmaciana agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
1.png)
